Please assess the completion status of the following clinical trial:

Trial Title: Dose Response of Fractional Exhaled Nitric Oxide (FeNO) to Inhaled Steroids in Mild-to-moderate Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis os asthma, taking 200-1000mcg budesonide or equivalent per day~* FENO greater than 30ppb on treatment~Exclusion Criteria:~* Recent RTI or prednisolone~* Smoking within 1 year or 10 pack years~* ABPA, COPD, bronchiectasis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- High dose ICS (Type: ACTIVE_COMPARATOR): Fluticasone Propionate 250mcg bid
- Low dose ICS (Type: ACTIVE_COMPARATOR): Fluticasone propionate 50mcg bid

Based on this trial design, predict the completion outcome and termination type (if applicable).